Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4777970
Max Phase: Preclinical
Molecular Formula: C50H65N11O11S2
Molecular Weight: 1060.27
Molecule Type: Unknown
Associated Items:
ID: ALA4777970
Max Phase: Preclinical
Molecular Formula: C50H65N11O11S2
Molecular Weight: 1060.27
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1)C(N)=O
Standard InChI: InChI=1S/C50H65N11O11S2/c1-27(2)42(43(53)65)61-50(72)40-26-74-73-25-39(59-44(66)33(52)23-41(63)64)49(71)57-36(20-28-10-4-3-5-11-28)46(68)58-38(22-30-24-54-34-13-7-6-12-32(30)34)48(70)55-35(14-8-9-19-51)45(67)56-37(47(69)60-40)21-29-15-17-31(62)18-16-29/h3-7,10-13,15-18,24,27,33,35-40,42,54,62H,8-9,14,19-23,25-26,51-52H2,1-2H3,(H2,53,65)(H,55,70)(H,56,67)(H,57,71)(H,58,68)(H,59,66)(H,60,69)(H,61,72)(H,63,64)/t33-,35-,36-,37-,38-,39-,40-,42-/m0/s1
Standard InChI Key: ISLPFBPCYWSSHO-LOWSNRHLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1060.27 | Molecular Weight (Monoisotopic): 1059.4306 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):